Innovative and results-driven Biomedical Researcher with a proven track record in identifying new therapeutic strategies for diseases with unmet clinical need. Possesses expertise in cellular and rodent models of metabolic disease, as well as proficiency in various surgical, histological, biochemical, and molecular biology techniques. Has successfully uncovered novel cellular pathways with potent lipo- and glucoregulatory effects. Utilized a specialized mouse model as a discovery tool and applied multi-omics approaches (genomics, proteomics, kinomics) to pre-clinically identify, validate, and de-risk new anti-diabetic INDs. Excited to leverage these skills to advance TNO's MHR research portfolio.